Nucleolin (NCL) on the cell surface is a novel cancer target molecule for tumor therapy, due to its abundance on the surface and prominence in various cancer cells, including gastric, breast, lung, and prostate cancers [5,6,7]. This evidence concerns the gene NUCLEOLIN and Familial prostate cancer.